| Literature DB >> 34900398 |
Chanting He1,2,3,4, Xiaoyan Zhao1, Yang Lei1, Jisheng Nie1, Xiaoting Lu1, Jing Song1, Linping Wang1, Huan Li1, Fangqu Liu1, Yidan Zhang1, Qiao Niu1,2,3.
Abstract
Aluminum is a known neurotoxin that can induce Aβ deposition and abnormal phosphorylation of tau protein, leading to Alzheimer disease (AD)-like damages such as neuronal damage and decreased learning and memory functions. In this study, we constructed a rat model of subchronic aluminum maltol exposure, and the whole-transcriptome sequencing was performed on the hippocampus of the control group and the middle-dose group. A total of 167 miRNAs, 37 lncRNAs, 256 mRNAs, and 64 circRNAs expression changed. The Kyoto Encyclopedia of Genes and Genomes showed that PI3K/AKT pathway was the most enriched pathway of DEGs, and IRS1 was the core molecule in the PPI network. circRNA/lncRNA-miRNA-mRNA networks of all DEGs, DEGs in the PI3K/AKT pathway, and IRS1 were constructed by Cytoscape. Molecular experiment results showed that aluminum inhibited the IRS1/PI3K/AKT pathway and increased the content of Aβ and tau. In addition, we also constructed an AAV intervention rat model, proving that inhibition of miR-96-5p expression might resist aluminum-induced injury by upregulating expression of IRS1. In general, these results suggest that the ceRNA networks are involved in the neurotoxic process of aluminum, providing a new strategy for studying the toxicity mechanism of aluminum and finding biological targets for the prevention and treatment of AD.Entities:
Keywords: IRS1; PI3K/AKT pathway; RNA sequencing; aluminum; ceRNA; miR-96-5p
Year: 2021 PMID: 34900398 PMCID: PMC8636738 DOI: 10.1016/j.omtn.2021.11.010
Source DB: PubMed Journal: Mol Ther Nucleic Acids ISSN: 2162-2531 Impact factor: 8.886
Figure 1MWM results of control, 10, 20, and 40 μmol/kg Al(mal)3 groups
(A) Experimental design: construction of a rat model of aluminum exposure. (B) Swimming speed of rats in each group. (C) The escape latency period in the positioning navigation experiment. (D) The target quadrant dwell time in the space exploration experiment. (E) The number of rats crossing the platform in the space exploration experiment. (F) Representative swimming trajectory in each group on the fifth and sixth day. Compared with the control group, ∗p < 0.05. N = 13.
Figure 2Effects of Al(mal)3 on neurons and synaptic structure
(A) The results of Nissl staining in hippocampal CA1 region of rats in control, 10-, 20-, and 40-μmol/kg Al(mal)3 groups. Magnification ×400. (B) Quantification of the number of neurons. N = 3. (C) The results of TEM in hippocampal CA1 region of rats in control, 10-, 20-, and 40-μmol/kg Al(mal)3 groups. Magnification ×60,000.The red arrow: synaptic structure. (D) Quantification of the average thickness of PSD. N = 3. Compared with the control group, ∗p < 0.05.
Figure 3Differential expression of miRNA, lncRNA, mRNA, and circRNA in hippocampus after aluminum exposure
(A) Volcano plot of DE-miRNAs. (B) Volcano plot of DE-lncRNAs. (C) Volcano plot of DE-mRNAs. (D) Volcano plot of DE-circRNAs. The red dots represent transcripts that were up-regulated in the aluminum-exposed group compared with the control group. The blue dots represent the down-regulated transcripts.
Figure 4GO terms, KEGG enriched pathways and PPI network of DEGs
(A) GO analysis of all the DEGs between control group and aluminum-exposed group. (B) Statistics of pathways enrichment of all the DEGs between control group and aluminum-exposed group. (C) PPI diagram. The red circle is IRS1.
DEGs in PI3K/AKT pathway of Al-treated rats compared to control
| Gene_name | Al-treated group (FPKM) | Control group (FPKM) | log2 (foldchange) | p value | Gene description | |
|---|---|---|---|---|---|---|
| 1 | Irs1 | 6.45276 | 10.3633 | −0.68349 | 0.00005 | insulin receptor substrate 1 |
| 2 | Gnb3 | 0.645884 | 19.8584 | −4.94233 | 0.00005 | G protein subunit beta 3 |
| 3 | Vwf | 6.46679 | 21.271 | −1.71777 | 0.00005 | von Willebrand factor |
| 4 | Itgb6 | 0.160207 | 1.46191 | −3.18984 | 0.00005 | integrin subunit beta 6 |
| 5 | Fn1 | 3.78279 | 9.79902 | −1.37319 | 0.00005 | fibronectin 1 |
| 6 | Col6a2 | 3.20574 | 5.8765 | −0.8743 | 0.00005 | collagen type VI alpha 2 chain |
| 7 | Sgk1 | 44.7435 | 115.641 | −1.3699 | 0.00005 | serum/glucocorticoid regulated kinase 1 |
| 8 | Fgf1 | 0.914646 | 3.67473 | −2.00635 | 0.00005 | fibroblast growth factor 1 |
| 9 | Cdkn1a | 5.23479 | 11.5729 | −1.14455 | 0.00005 | cyclin dependent kinase inhibitor 1A |
| 10 | Thbs2 | 0.88797 | 2.62285 | −1.56255 | 0.00005 | thrombospondin 2 |
| 11 | Lama2 | 1.74869 | 3.9672 | −1.18184 | 0.00005 | laminin subunit alpha 2 |
| 12 | Igf2 | 7.55965 | 48.7827 | −2.68998 | 0.00005 | insulin-like growth factor 2 |
| 13 | Col9a3 | 5.089 | 9.22543 | −0.858233 | 0.0002 | collagen type IX alpha 3 chain |
| 14 | Col1a1 | 1.49169 | 2.73112 | −0.872545 | 0.00025 | collagen type I alpha 1 chain |
| 15 | Lamb2 | 7.48994 | 10.8247 | −0.531298 | 0.0007 | laminin subunit beta 2 |
Figure 5The ceRNA networks
(A) circRNA-miRNA-mRNA network of all the DEGs. (B) lncRNA-miRNA-mRNA network of all the DEGs. (C) circRNA-miRNA-mRNA network of DEGs in PI3K/AKT pathway. (D) lncRNA-miRNA-mRNA network of DEGs in PI3K/AKT pathway. (E) circRNA-miRNA-IRS1 network. (F) lncRNA-miRNA-IRS1 network.
Figure 6Laboratory verification results
(A) RT-PCR validation of RNA-seq for differentially expressed transcripts. N = 6. (B) The changes of Aβ1–42 content in rat hippocampus were measured by ELISA. N = 4. (C) Changes in protein expression of PI3K/AKT pathway after aluminum exposure. (D) Protein expression statistics graph. N = 4. (E) Expression distribution of Aβ1–42 in hippocampal CA1 area. (F) The percentage of Aβ1–42 positive area in the CA1 area of the hippocampus. N = 3. Compared with the control group, ∗p < 0.05.
Figure 7Effect of miR-96-5p on learning and memory impairment in rats induced by aluminum
(A) Experimental design: construction of a rat model of AAV intervention. (B) Schematic diagram of AAV vector. (C) Representative fluorescence image of rat hippocampus after the establishment of the AAV intervention model. Magnification ×40. (D) Swimming speed of rats in each group. (E) The escape latency period in the positioning navigation experiment. (F) The target quadrant dwell time in the space exploration experiment. (G) The number of rats crossing the platform in the space exploration experiment. Compared with the control group, ∗p < 0.05. Compared with the Al(mal)3 group, #p < 0.05. N = 10.
Figure 8Blocking of miR-96-5p reduced the neurotoxicity of aluminum through the IRS1/PI3K/AKT pathway
(A) The results of Nissl staining in hippocampal CA1 region. Magnification ×400. (B) Quantification of the number of neurons. N = 3. (C) The results of TEM in hippocampal CA1 region. Magnification ×60,000. The red arrow: synaptic structure. (D) Quantification of the average thickness of PSD. N = 3. (E) Detection of miR-96-5p and IRS1 mRNA level in AAV intervention model. N = 4. (F) The changes of Aβ1–42 content in rat hippocampus were measured by ELISA. N = 4. (G) Changes in protein expression of IRS1/PI3K/AKT pathway in AAV intervention model. (H) Protein expression statistics graph. N = 4. Compared with the control group, ∗p < 0.05. Compared with the Al(mal)3 group, #p < 0.05.
The specific primers used in RT-PCR
| Gene | Primer sequences | |
|---|---|---|
| Irs1 | F: 5′-AAGCACCTATGCCAGCATCAAC-3′ | R: 5′-GAGGATTGCTGAGGTCATTTAGGTC-3′ |
| Gnb3 | F: 5′-GACCTGTCGCCAGACTTTCA-3′ | R: 5′-CTGCCCTCAGGTCAAAGAGG-3′ |
| Vwf | F: 5′-ACTAGACGTTTCCCTTGCCG-3′ | R: 5′-GATGTCCAGGTATGGCTCGG-3′ |
| Itgb6 | F: 5′-GCATCCTCTTCCCACACCAA-3′ | R: 5′-CCAAGTCCCACAGGCTTGAT-3′ |
| Fn1 | F: 5′-GGAGCCTTCACACATCACCA-3′ | R: 5′-GTGGCCTGGAATGGTAGCTT-3′ |
| Col6a2 | F: 5′-GTGATGGTCCAAAGGGGGAG-3′ | R: 5′-CTTGGCTCCTTTACTGCCGA-3′ |
| Sgk1 | F: 5′-GCCAGTGCCTTGGGTTATCT-3′ | R: 5′-ATGTTCTCCTTGCAGAGCCC-3′ |
| Fgf1 | F: 5′-ATGGACACCGAAGGGCTTTT-3′ | R: 5′-AAACCAGTTCTTCTCCGCGT-3′ |
| Thbs2 | F: 5′-GCTACCAATGCCACCTACCA-3′ | R: 5′-AAGCATCTCCGATTCCGTCC-3′ |
| LNC000559 | F: 5′-TATCAGTCTCAACCAGTCTAAACCC-3′ | R: 5′-TAACAGCTAGGAAGTCGCAACA-3′ |
| LNC000152 | F: 5′-TGCCACATCTGGTGCTTGC-3′ | R: 5′-GACCGAGGCAACTTGTAAACC-3′ |
| Gapdh | F: 5′-CCATTCTTCCACCTTTGATGCT-3′ | R: 5′-TGTTGCTGTAGCCATATTCATTGT-3′ |
| circ_0,005,551 | F: 5′-CATTGGCTAAAGAGAGGCAGAA-3′ | R: 5′-TCTGGGCTTGCTGTATGTGG-3′ |
| rno-miR-96-5p | F: 5′-GGCACTAGCACATTTTTGCTAAA- 3′ | Sequence selected from Taraka 638313 reagent |
| rno-miR-143-3p | F: 5′-GCAGTGCTGCATCTCTGGAA-3′ | Sequence selected from Taraka 638313 reagent |
| rno-miR-144-3p | F: 5′-CCGCTACAGTATAGATGATGTACTAA-3′ | Sequence selected from Taraka 638313 reagent |
| rno-miR-145-3p | F: 5′-AGTTTTCCCAGGAATCCCTAAA-3′ | Sequence selected from Taraka 638313 reagent |
| rno-miR-183-5p | F: 5′-TATGGCACTGGTAGAATTCACTAAA-3′ | Sequence selected from Taraka 638313 reagent |
| rno-miR-337-3p | F: 5′-TTCAGCTCCTATATGATGCCTTTAA-3′ | Sequence selected from Taraka 638313 reagent |
| U6 | F: 5′-GGAACGATACAGAGAAGATTAGC-3′ | R: 5′-TGGAACGCTTCACGAATTTGCG-3′ |